Novartis AG (ADR) (NVS)
$55.85
0.55 (+0.99%)
| CAPS Rating |
|
|---|---|
| Open | $55.81 |
| Previous Close | $55.30 |
| Daily Range | $55.66 - $55.96 |
| 52-Week Range | $33.34 - $54.96 |
| Market Cap | $126.85B |
| P/E Ratio | 15.25 |
| Dividend (Yield) | 1.45 (2.60%) |
| Volume | 1,758,307 |
| Average Daily Volume | 1,400,000 |
NVS
VS S&P 500 (SPY)
How do you think NVS will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NVS Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NVS News and Commentary
- MARKET SNAPSHOT: U.S. Stocks End At 13-month Highs Ahead Of Holiday – SmartMoney
- Teva Files 2nd Citizen's Petition To Block Generic Copaxone – SmartMoney
- Dream Stocks for Biotech Investors – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 10 Terrific Dividend-Paying Stocks – SmartMoney
- UPDATE:Novartis Opens US-Based Flu-Vaccine Manufacturing Plant – SmartMoney
- Novartis Opens US-Based Flu-Vaccine Manufacturing Plant – SmartMoney
- Novartis Inaugurates US Cell-Culture Flue Vaccine Plant – SmartMoney
- Seeking Alpha on Novartis AG ADS – Ockham-RazorWire
- CDC: Sees Slight Decline In H1N1 Influenza Illnesses – SmartMoney
- WHO: Mutated H1N1 Virus In Norway Sensitive To Antiviral Drugs – SmartMoney
- Now Is the Time to Buy Risk – The Motley Fool
- EU Panel: Affirm Benefits Of Celvapan, Focetria, Pandemrix – SmartMoney
- Pfizer Dodges a Bullet – The Motley Fool
- Pfizer's Generic Growth, With a Side of Sashimi – The Motley Fool
- UPDATE: FDA Panel Votes Against Approving Xolair In Children – SmartMoney
- FDA Panel Split On Benefits of Genentech's Xolair For Children – SmartMoney
- The Government Won't Be There for You – The Motley Fool
- FDA Panel Questions Dosing Levels For Novartis's Xolair – SmartMoney
RSS Headlines
Fool UK
